Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Enabling Genomic Technologies and Screening Asia

11 Sep 2014 - 12 Sep 2014 - Singapore, Asia



Bookmark and Share


Select Biosciences South East Asia is delighted to announce that our Enabling Genomic Technologies and Screening Asia Conference and Exhibition will take place at the Biopolis, Singapore on the 11th and 12th September 2014. 

We are co-hosting the event with The Genome Institute of Singapore (GIS) at A*STAR’s state of the art conference facilities within the Biopolis, the Biomedical Science hub for Singapore. 

The event will have two concurrent conference tracks, with presentations from the leading scientists within these fields. The first conference track will cover Enabling Genomic Technologies and we are proud to welcome Dr. Kosuke Yusa as our Keynote Speaker for the meeting. Dr. Kosuke Yusa is a member of the Sanger Institute Faculty, UK.

We are also pleased to welcome both Dr. Ramanuj DasGupta, Group Leader/Senior Investigator, GIS, Cancer Therapeutics & Stratified Oncology, Assoc. Professor, NYU Cancer Institute and Dr. Pauline Ng, Group Leader/Senior Investigator, GIS, Chief Informatics Officer, Polaris. They will be representing our partner, The Genome Institute Singapore (GIS).  

The second track is entitled Screening Asia and we are privileged to have Dr. Alex Matter, M.D., Professor David Virshup and Dr. Litao Zhang, as our Keynote Speakers. 

Dr. Matter is the CEO of the Experimental Therapeutics Centre, A*STAR, Singapore. Professor Virshup is the inaugural Director of the Cancer and Stem Cell Biology Program at the Duke-NUS Graduate Medical School in Singapore. Dr Litao Zhang is the Vice President of Leads Discovery and Optimization, Bristol-Myers Squibb.

Attending this meeting will give you an excellent opportunity for networking with like-minded peers, helping you to find unique solutions and build long term collaborations. With all delegates having full access to both conference tracks, everyone has the opportunity to develop the specific agenda of their choice. 

Select Biosciences South East Asia is looking forward to welcoming you to this exciting event, and we hope that your experience will be both informative and enjoyable.



Further information
Scientific News
Common Cell Transformed into Master Heart Cell
By genetically reprogramming the most common type of cell in mammalian connective tissue, researchers at the University of Wisconsin—Madison have generated master heart cells — primitive progenitors that form the developing heart.
Improving Regenerative Medicine
Lab-created stem cells may lack key characteristics, UCLA research finds.
Muscles on-a-Chip
This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Bile Acid Supports Production of Blood Stem Cells
A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Edited Stem Cells Offer Hope of Precision Therapy for Blindness
Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!